Snowden Capital Advisors LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1903055 New York, NY

Position in TEVA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,149,381

+$303,146 QoQ

Shares Held

63,441

+3.5% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#261

of 671 holders

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Snowden Capital Advisors LLC holds $4,377,396 across 7 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (49.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd This page	63,441	$2,149,381
2	NBIX	Neurocrine Biosciences Inc	5,428	$914,835
3	UTHR	UNITED THERAPEUTICS Corp	1,019	$552,124
4	ZTS	Zoetis Inc.	6,658	$478,443
5	HLN	Haleon plc	17,835	$166,400
6	EVO	Evotec SE	25,379	$71,061
7	AQST	Aquestive Therapeutics, Inc.	10,854	$45,152

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,149,381	63,441	+3.5%	Shares	Sole	2026-08-13
2026-03-31	$1,846,235	61,296	+97.8%	Shares	Sole	2026-05-15
2025-12-31	$967,322	30,994	-19.2%	Shares	Sole	2026-02-17
2025-09-30	$774,710	38,352	-3.1%	Shares	Sole	2025-11-14
2025-06-30	$663,578	39,593	+10.3%	Shares	Sole	2025-08-14
2025-03-31	$551,521	35,883	+10.2%	Shares	Sole	2025-05-14
2024-12-31	$717,688	32,563	-11.8%	Shares	Sole	2025-02-14
2024-09-30	$665,172	36,913	+16.7%	Shares	Sole	2024-11-14
2024-06-30	$513,955	31,628	-4.7%	Shares	Sole	2024-08-14
2024-03-31	$468,395	33,196	+14.2%	Shares	Sole	2024-05-15
2023-12-31	$303,511	29,072	+0.4%	Shares	Sole	2024-02-14
2023-09-30	$295,218	28,943	+179.5%	Shares	Sole	2023-11-14
2023-06-30	$77,980	10,356	+25158.5%	Shares	Sole	2023-08-14
2021-12-31	$328	41	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.